Inflammatory mediators and bronchopulmonary dysplasia.
Open Access
- 1 July 1995
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood: Fetal & Neonatal
- Vol. 73 (1) , F1-F3
- https://doi.org/10.1136/fn.73.1.f1
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasiaThe Journal of Pediatrics, 1994
- Interleukin-8 in bronchoalveolar lavage samples as predictor of chronic lung disease In premature infantsThe Lancet, 1994
- Proteinase-antiproteinase balance in tracheal aspirates from neonatesEuropean Respiratory Journal, 1994
- Increased soluble ICAM-1 in tracheal aspirates of infants with bronchopulmonary dysplasiaThe Lancet, 1993
- Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung diseaseThe Journal of Pediatrics, 1993
- Protease inhibitors in bronchoalveolar lavage fluid from neonates with special reference to secretory leukocyte protease inhibitorActa Paediatrica, 1992
- Soluble interleukin-2 receptor levels in infants with bronchopulmonary dysplasiaPediatric Pulmonology, 1992
- Elastase α-proteinase inhibitor and lactoferrin concentrations in endotracheal aspirates of ventilated newbornsPediatric Pulmonology, 1992
- Sequential changes in pulmonary mechanics in the very low birth weight (≤1000 grams) infantThe Journal of Pediatrics, 1988
- Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia.Journal of Clinical Investigation, 1983